Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether the investigational drug galantamine-CR
(Reminyl- Controlled Release capsule) is useful in improving problems with memory in bipolar
patients with stable mood. This study is being done because a large proportion of patients
with bipolar disorder experience significant memory problems, even when their mood is stable,
after adequate treatment. These memory problems have been associated with poor daily social
functioning. Studying galantamine-CR in this population may provide a new clinical way to
combat memory problems in stable patients with bipolar disorder.